Europe has historically been rich in physicians with innovative ideas but has lagged in turning those ideas into novel devices. MD Start, a new incubator, backed by a group of leading device companies and VC firms, hopes to turn those ideas into viable companies.

MD Start, a European medical device incubator, was launched in 2009 as a collaboration between medtech giant Medtronic Inc. and Paris-based venture firm Sofinnova Partners, to help European physicians bring their ideas to market. The incubator announces two new shareholders in the venture, reinforcing both its US and European connections: Milan-based cardiovascular leader Sorin Group SPA and US venture firm Versant Ventures.

Zydus Cadila expects domestic sales to improve and the US generics business to grow in “mid to high” single digits during FY21 after both saw a coronavirus-related hit in Q1. Meanwhile, approvals for a few biologics are expected, its COVID-19 vaccine candidate has just entered Phase II studies and remdesivir launch looms.